MC
SCMP

Menta Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Menta Capital’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-52,654
Closed -$621K – 913
2017
Q3 		$621K Sell
52,654
-61,676
-54% -$692K 0.09% 402
2017
Q2 		$1.2M Sell
114,330
-25,515
-18% -$260K 0.14% 258
2017
Q1 		$1.54M Sell
139,845
-25,243
-15% -$293K 0.15% 231
2016
Q4 		$2.24M Sell
165,088
-60,376
-27% -$842K 0.19% 153
2016
Q3 		$2.77M Buy
225,464
+46,882
+26% +$552K 0.26% 105
2016
Q2 		$1.96M Buy
178,582
+117,310
+191% +$1.31M 0.27% 60
2016
Q1 		$670K Sell
61,272
-605
-1% -$7.64K 0.09% 376
2015
Q4 		$1.07M Buy
61,877
+42,307
+216% +$759K 0.14% 238
2015
Q3 		$389K Buy
+19,570
New +$449K 0.06% 506
2015
Q2 		– Sell
-60,050
Closed -$934K – 827
2015
Q1 		$934K Sell
60,050
-42,957
-42% -$666K 0.12% 284
2014
Q4 		$1.47M Buy
103,007
+6,500
+7% +$68.7K 0.21% 151
2014
Q3 		$627K Buy
96,507
+43,100
+81% +$286K 0.1% 315
2014
Q2 		$369K Buy
53,407
+28,600
+115% +$202K 0.07% 352
2014
Q1 		$177K Buy
+24,807
New +$212K 0.05% 334

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Menta Capital's SCMP Position: Q4 2017 in Review

Menta Capital sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 52,654 shares — an estimated $621K sold.

Menta Capital first reported a position in SCMP in Q1 2014 and held it in 14 quarters. The position peaked at $2.77M in Q3 2016. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • Menta Capital reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Menta Capital sold 52,654 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $621K.
  • Menta Capital first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2014 and held it in 14 quarters.
  • Menta Capital's Sucampo Pharmaceuticals, Inc. position peaked at $2.77M in Q3 2016.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Menta Capital's 13F filing for Q4 2017, filed 14 Feb 2018.